Interestingly, UPR kinetic studies in HCC revealed that IRE1α is activated during tumor initiation and the PERK pathway during tumor progression, while ATF6 is only moderately activated in developed tumors (39). Here, ATF6 is linked to hepatocellular carcinoma.